Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level.
Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) manufactured in November 2021 to the consumer leve
Attractive incentives and rebates in the new income tax regime, steep hike in capital investments, creation of new jobs, biggest outlay in railways, greater emphasis on the rural sector, social-sector schemes, infrastructure creation, and the middle class has brought cheers to taxpayers and the busi